Saturday 17 October 2026
Export MDAI’s income statement to Excel — free account
Spectral AI, Inc.
MDAI Healthcare Medical Devices
Spectral AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $19.7 million, down 33.6% from fiscal 2024. In the quarter to June 2026, revenue fell 30.4%, EPS grew 58.1%, free cash flow fell 21.9% and total debt rose 44.9%, each against the same quarter a year earlier.
1.51
0.03
−1.95%
Follow MDAI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
3.61 | 2.76 | 1.92 | 2.59 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(13.55) | (12.52) | (14.76) | (23.99) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.42 | 2.33 | 1.41 | 2.42 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.08) | (3.26) | (2.80) | (8.13) | |
EV/FCF |
(4.08) | (3.26) | (2.80) | (8.13) | |
Quick Ratio |
0.76 | 0.60 | 0.81 | 0.73 | |
Current Ratio |
0.90 | 0.75 | 0.94 | 0.85 | |
Net Debt/EBITDA |
0.73 | 4.43 | 5.19 | 1.30 | |
Debt/Assets |
56.88% | 25.39% | 25.87% | 43.01% | |
Debt/Equity |
(0.92) | (0.51) | (0.97) | (0.80) | |
Asset Turnover |
0.87 | 0.88 | 1.17 | 1.72 | |
Operating CF/Net income |
0.98 | 1.09 | (2.43) | 0.70 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(11.44) | — | — | — | |
Research and Development Expense of Revenue |
48.13% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
106.16% | 100.18% | 135.73% | 130.85% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
22.90% | 4.59% | 5.95% | 6.88% | |
Graham Net Nets |
(0.25) | (0.23) | (0.20) | (0.17) | |
Graham Number |
1.68 | 1.79 | 1.19 | 2.28 | |
Earnings Yield |
(19.25%) | (34.90%) | (20.64%) | (32.46%) | |
Free Cash Flow Yield |
(23.20%) | (26.01%) | (26.34%) | (11.50%) | |
Revenue per Share |
0.11 | 0.13 | 0.15 | 0.14 | |
Operating CF per Share |
(0.13) | (0.12) | (0.10) | (0.09) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.13) | (0.12) | (0.10) | (0.09) | |
Cash per Share |
0.44 | 0.37 | 0.58 | 0.40 | |
Shareholders Equity per Share |
(0.38) | (0.28) | (0.22) | (0.31) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.38) | (0.28) | (0.22) | (0.31) | |
Free Cash Flow |
(4.10) | (3.73) | (2.55) | (2.50) | |
Working Capital |
(2.08) | (5.29) | (1.17) | (2.30) | |
Net Current Asset Value |
(13.70) | (10.56) | (7.68) | (10.04) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.32 | 1.64 | 1.89 | 1.91 | |
Average Payables |
1.86 | 2.27 | 3.52 | 2.67 | |
Average Inventory |
0.64 | 0.63 | 0.63 | 0.45 | |
Average Assets |
17.72 | 19.23 | 16.75 | 13.45 | |
Average Common Equity |
(10.60) | (5.22) | (6.49) | (6.27) |
Columns are period end dates